Luye Pharma Group Financial Overview
Luye Pharma Group's market cap is currently $1.43B. The company's EPS TTM is $0.011748733; its P/E ratio is 26.71; Luye Pharma Group is scheduled to report earnings on August 28, 2025, and the estimated EPS forecast is $0.01. See an overview of income statement, balance sheet, and cash flow financials.
